CN Patent

CN116474108A — 成纤维细胞活化蛋白(fap)-靶向成像和治疗

Assigned to Purdue Research Foundation · Expires 2023-07-25 · 3y expired

What this patent protects

本发明涉及成纤维细胞活化蛋白(FAP)‑靶向成像和治疗。本教导通常涉及用于将患者的肿瘤微环境成像的缀合物和方法，和涉及用于将患者的肿瘤微环境中的癌症相关成纤维细胞(CAF)成像的缀合物和方法。本教导通常涉及制备包含成纤维细胞活化蛋白(FAP)抑制剂的缀合物的方法。

USPTO Abstract

本发明涉及成纤维细胞活化蛋白(FAP)‑靶向成像和治疗。本教导通常涉及用于将患者的肿瘤微环境成像的缀合物和方法，和涉及用于将患者的肿瘤微环境中的癌症相关成纤维细胞(CAF)成像的缀合物和方法。本教导通常涉及制备包含成纤维细胞活化蛋白(FAP)抑制剂的缀合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116474108A
Jurisdiction
CN
Classification
—
Expires
2023-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Purdue Research Foundation
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.